New study shows artificial pancreas works for length of entire school term
17 September 2015Technology assisting people with type 1 diabetes edges closer to perfection.
Technology assisting people with type 1 diabetes edges closer to perfection.
A new method for developing stem cells enables the production of liver and pancreatic cells in “clinically relevant” quantities for the first time, paving the way for regenerative therapies.
Cambridge research funded by the health charity Diabetes UK has for the first time successfully demonstrated the potential of an ‘artificial pancreas’ in preventing night-time hypoglycaemia in adults with Type 1 diabetes.
A multi-disciplinary centre of excellence which aims to bring cutting-edge pancreatic research from the bench to the bedside is launched.